Fortis Healthcare Limited

Fortis Healthcare Closes Trading Window from Jan 1, 2026 for Q3 FY26 Results

Fortis Healthcare Limited will close its trading window from January 1, 2026. The window will reopen 48 hours after the declaration of the un-audited financial results for the quarter ending December 31, 2025. This measure is in line with the company's insider trading policy.

Fortis Healthcare to Invest ₹840 Cr in Bengaluru, Acquires People Tree Hospital for ₹430 Cr

Fortis Healthcare will invest ~₹840 crore in Bengaluru, acquiring People Tree Hospital for ₹430 crore and planning an additional ₹410 crore investment to scale capacity to 300+ beds. The deal is expected to close by January 2026. This expansion aligns with Fortis' strategy to strengthen its presence in Bengaluru.

Fortis Healthcare to acquire TMI Healthcare for ₹430 Crore, expanding Bengaluru presence

Fortis Healthcare's subsidiary will acquire TMI Healthcare Private Limited for ₹430 Crore. The deal includes hospital operations, land, and buildings. This acquisition aims to expand Fortis's network in Bengaluru. The transaction is expected to close by January 2026.

Fortis Healthcare Receives BSE Approval for Debenture Modifications

Fortis Healthcare Limited announced that it received final approval from BSE Limited on December 19, 2025, for modifications to its Debenture terms. This follows a prior intimation on December 4, 2025.

Fortis Healthcare Receives Final BSE Approval for Debenture Modifications

Fortis Healthcare Limited received final approval from BSE Limited on December 19, 2025, for modifications to its debenture terms. This follows a previous intimation on December 4, 2025.

Fortis Healthcare: Director Appointment & Resignation on Dec 19, 2025

Fortis Healthcare Limited appointed Mr. Mohd Shahazwan Bin Mohd Harris as an Additional Director (Non-Executive & Non-Independent) effective December 19, 2025. Concurrently, Mr. Lim Tsin Lin resigned from his position as Non-Executive & Non-Independent Director, effective December 19, 2025.

Fortis Healthcare: Director Mohd Shahazwan Appointed, Lim Tsin Lin Resigns

Fortis Healthcare appointed Mr. Mohd Shahazwan Bin Mohd Harris as Additional Director. Mr. Lim Tsin Lin resigned as Non-Executive & Non-Independent Director. Both changes are effective December 19, 2025. Mr. Harris has extensive experience in investments and corporate strategy.

Fortis Healthcare Appoints Mohd Shahazwan Bin Mohd Harris as Director; Lim Tsin Lin Resigns

Fortis Healthcare appointed Mohd Shahazwan Bin Mohd Harris as Additional Director (Non-Executive & Non-Independent) effective December 19, 2025. Concurrently, Lim Tsin Lin resigned from his Non-Executive & Non-Independent Director position on the same date due to other commitments.

Fortis Healthcare Appoints Mohd Shahazwan Bin Mohd Harris, Lim Tsin Lin Resigns

Fortis Healthcare appointed Mr. Mohd Shahazwan Bin Mohd Harris as an Additional Director (Non-Executive & Non-Independent) effective December 19, 2025. Mr. Lim Tsin Lin resigned as Non-Executive & Non-Independent Director on the same date due to other commitments.

Fortis Healthcare: No Physical Share Transfer Requests Re-lodged in November 2025

Fortis Healthcare Limited reports no physical share transfer requests were received or processed during November 2025 under SEBI's special window. The company's Registrar and Share Transfer Agent confirmed NIL activity for the period.

Fortis Healthcare Announces Special Window for Physical Share Transfer Re-lodgement

Fortis Healthcare is offering a special window from July 7, 2025, to January 6, 2026, for shareholders to re-lodge physical share transfer deeds. This applies to transfers lodged before April 1, 2019, that were rejected or could not be re-lodged. Shareholders should contact KFin Technologies Limited for assistance.

Fortis Healthcare modifies terms of ₹1,550 crore NCDs

Fortis Healthcare modifies terms of its ₹1,550 crore non-convertible debentures (NCDs), including spread reduction, fee adjustments and security changes.

Escorts Heart Institute files writ petition against CGST Delhi

Escorts Heart Institute, a Fortis subsidiary, files a writ petition in Delhi High Court against CGST Delhi over GST payment allegations involving ₹6.66 crore plus interest and penalty.

Intimation of Record Date for Interest Payment on NCDs

Fortis Healthcare sets December 5, 2025, as the record date for interest payment on NCDs (ISINs: INE061F07044, INE061F07051, INE061F07069), with the payment due on December 20, 2025.

Fortis Healthcare Limited announces updates regarding physical share transfer requests

Fortis Healthcare Limited announced updates on re-lodgement of physical share transfer requests as per SEBI guidelines. No requests were received, approved, or rejected during the month ended October 30, 2025.

Fortis Healthcare: Voting results for appointment of Director

Fortis Healthcare announces the successful appointment of Dr. Keith Hsiu Chin Lim as a Non-Independent & Non-Executive Director via postal ballot with a significant majority.

Fortis Healthcare shareholders approve Dr. Keith Hsiu Chin Lim's appointment as Non-Executive Director

Fortis Healthcare shareholders approved Dr. Keith Hsiu Chin Lim's appointment as a Non-Executive Director via postal ballot, with 99.32% votes in favor by November 15, 2025.

Fortis Healthcare Reports Strong Q2 FY26 Results, Operational Growth, and Releases Investors' Meet Transcript

Fortis Healthcare reported strong Q2 FY26 results with consolidated revenue up 17.3% to ₹2,331 crores and EBITDA up 28% to ₹556 crores. Hospital and diagnostics segments showed robust growth and margin expansion, alongside strategic bed additions and acquisitions.

Fortis Healthcare releases audio recording of Q2 FY26 earnings call

Fortis Healthcare released the audio recording of its Q2 FY26 investors/analysts meet held on November 12, 2025, discussing financial results for the quarter ended September 30, 2025.

Fortis Healthcare Announces Un-Audited Financial Results for Quarter Ended September 30, 2025

Fortis Healthcare announced its un-audited financial results for the quarter ended September 30, 2025, with consolidated total income from operations at ₹2,35,402 lakh and net profit after tax at ₹32,882 lakh.

Fortis Healthcare Announces Q2 FY26 Financial Results

Fortis Healthcare announced Q2 FY26 results with revenue at ₹2,331 Cr, up 17.3% YoY, and PAT at ₹329 Cr, up 70.3% YoY. They expanded to Greater Noida and Lucknow.

Fortis Healthcare Announces Q2 FY26 Financial Results

Fortis Healthcare announced Q2 FY26 results with revenue at ₹2,331 Cr, up 17.3% YoY and PAT at ₹329 Cr, up 70.3% YoY. They expanded to Greater Noida and Lucknow. Expect continued positive momentum in diagnostics.

Fortis Healthcare Approves Un-Audited Standalone & Consolidated Financial Results

Fortis Healthcare Limited approved the Un-Audited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2025. Standalone revenue from operations for the quarter ended September 30, 2025, was ₹45,581 lacs.

Fortis Healthcare Approves Unaudited Standalone & Consolidated Results for Quarter Ended Sep 2025

Fortis Healthcare board approves unaudited standalone & consolidated financial results for quarter ended September 30, 2025. Standalone revenue from operations is ₹45,581 lacs, and net profit is ₹12,509 lacs.

Completion of Open Offer by IHH Healthcare Berhad

IHH Healthcare Berhad announces completion of Fortis and Malar Open Offers. Post-offer, IHH holds 31.17% of Fortis and 62.73% of Malar.

IHH Healthcare Berhad announces updates on Fortis & Malar Open Offers

IHH announces updates on open offers for Fortis & Malar shares. Post tendering period close on Nov 4, 2025, IHH's indirect holding in Fortis will be 31.17% and in Malar 62.73%.

Fortis Healthcare schedules Q2FY26 & H1FY26 results conference call on November 12, 2025

Fortis Healthcare will hold a virtual conference call on November 12, 2025, at 11:00 am IST to discuss its unaudited Q2FY26 and H1FY26 financial results.

Newspaper Publication for Postal Ballot Notice Completion

Fortis Healthcare Limited announced the completion of electronic transmission of Postal Ballot Notice to members through newspaper advertisements in Financial Express and Rozana Spokesman on October 17, 2025.

Fortis Healthcare: Open Offer tendering period to commence on 20 Oct 25

Fortis Healthcare announces the tendering period for the Fortis Open Offer and Malar Open Offer will commence from 20 October 2025 and will remain open until 4 November 2025.

Fortis Healthcare: Postal Ballot for Director Appointment

Fortis Healthcare seeks shareholder approval via postal ballot for appointing Dr. Keith Hsiu Chin Lim as Non-Independent & Non-Executive Director. E-voting: Oct 17 - Nov 15, 2025. Results by Nov 18, 2025.

Fortis Healthcare: Newspaper Publication on Independent Directors' Recommendations

Fortis Healthcare published recommendations from its Independent Directors' Committee regarding an open offer to shareholders on October 16, 2025, across multiple newspapers, complying with SEBI regulations.

Fortis Healthcare reports NIL requests for physical share transfer re-lodgement under SEBI circular

Fortis Healthcare reports no physical share transfer re-lodgement requests for September 2025 under the special SEBI window, as confirmed by KFin Technologies Limited.

Fortis Healthcare reports details of listed debt securities as of September 30, 2025

Fortis Healthcare reported details of its listed debt securities issued via private placement as of September 30, 2025, as per SEBI regulations, totaling ₹1550 crore outstanding.

Fortis Open Offer and Malar Open Offer Letters dispatched on 9 Oct 2025

Fortis Healthcare Limited announced the dispatch of updated letters of offer for the Fortis and Malar Open Offers following SEBI approval. The offer prices include interest for eligible shareholders.

Fortis Healthcare files SEBI Regulation 74(5) certificate for Q2 FY26

Fortis Healthcare submitted its Regulation 74(5) certificate for the quarter ended September 30, 2025, confirming compliance with SEBI (Depositories and Participants) Regulations.

IHH Healthcare's Open Offer for Fortis Healthcare Approved by SEBI

SEBI approves IHH Healthcare's open offer for Fortis Healthcare and Fortis Malar Hospitals. The offer includes subscription of new equity shares and mandatory open offers to acquire additional shares.

Fortis Healthcare's O&M Agreement for Gleneagles BGS Hospital Effective October 1, 2025

Fortis Healthcare announces schedule of Investor Meetings

Fortis Healthcare Appoints Dr. Keith Hsiu Chin Lim as Director; Mr. Tomo Nagahiro Resigns

Fortis Healthcare reports no re-lodgement requests for physical share transfers in July-August 2025

Fortis Subsidiary IHL Enters Tripartite Agreement with UPSIDA and R.R. Lifesciences

CRISIL upgrades Fortis Healthcare's long-term rating to 'CRISIL AA+/Stable'

Fortis Subsidiary IHL Sub-leases Greater Noida Hospital for Delhi-NCR Expansion

Fortis Healthcare's Scheme of Arrangement with subsidiaries becomes effective

Fortis Healthcare's ESG Rating Upgraded by CRISIL to 'Strong' Category

Fortis Healthcare signs O&M agreement for 550-bed super specialty hospital in Lucknow

Fortis Informs Shareholders of SEBI's Special Window for Physical Share Re-lodgement

Fortis Healthcare AGM approves financial results, dividend & appointments.

Fortis Healthcare provides audio recording of Q1 FY26 earnings call

Fortis Healthcare Approves Unaudited Standalone & Consolidated Results for Q1 Ended June 30, 2025